2016
The Approach to Pseudomonas aeruginosa in Cystic Fibrosis
Talwalkar JS, Murray TS. The Approach to Pseudomonas aeruginosa in Cystic Fibrosis. Clinics In Chest Medicine 2016, 37: 69-81. PMID: 26857769, DOI: 10.1016/j.ccm.2015.10.004.BooksConceptsCystic fibrosisAcute pulmonary exacerbationsDuration of administrationSpecific patient characteristicsStandard of careSite of carePseudomonas aeruginosaPulmonary exacerbationsAntipseudomonal antibioticsPatient characteristicsTreatment optionsEpidemiologic linkChronic infectionHigh prevalenceTreatment decisionsNew vaccinesEarly identificationAggressive useFibrosisAntibiotic selectionInfectionCareLaboratory methodsAeruginosaExacerbation
2007
Macrolides in Cystic Fibrosis
McArdle JR, Talwalkar JS. Macrolides in Cystic Fibrosis. Clinics In Chest Medicine 2007, 28: 347-360. PMID: 17467553, DOI: 10.1016/j.ccm.2007.02.005.BooksConceptsCystic fibrosisChronic pulmonary diseaseDevelopment of bronchiectasisMajority of patientsProgressive lung diseasePositive therapeutic effectHost inflammatory responseAirway surface liquidChronic infection resultsAzithromycin administrationDiffuse panbronchiolitisPulmonary diseaseClinical benefitLung diseaseMucociliary clearanceInflammatory responseTherapeutic effectInfection resultsTissue damageViscous secretionsPatientsSurface liquidDiseaseFibrosisMacrolide antibiotics